NDC 86136-018-10 - Nobatol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86136-018
- Requested NDC
- 86136-018-10
- Package NDCs from labels
- 86136-018-10, 86136-018-50
- Manufacturer
- MWI/VetOne
- Effective date
- 2023-06-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nobatol - MWI/VetOne | MWI/VetOne | 2023-06-08 | PRESCRIPTION ANIMAL DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Phenobarbital | PHENOBARBITAL | REMEDYREPACK INC. | 4e2910f2-173d-4b5c-aad3-44f4ab40d8cb | 2026-09-02 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | REMEDYREPACK INC. | 4e6f2a3b-c6e2-488e-827a-e8646279532d | 2026-08-31 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Chartwell RX, LLC | 74428144-fb24-40a5-a670-3b876e2d116c | 2026-08-27 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | REMEDYREPACK INC. | 6c7189e8-949e-4ecd-bfdf-5347d4f1a387 | 2026-08-05 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | REMEDYREPACK INC. | 9efb749b-085d-4a19-9342-e26c635800a8 | 2026-08-05 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | REMEDYREPACK INC. | 3e7637d9-2a8a-4063-8b14-1d1444629a15 | 2026-08-05 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | REMEDYREPACK INC. | b43c3611-24f6-4eaf-ac68-c2807f92ca98 | 2026-08-04 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Sun Pharmaceutical Industries, Inc. | fa09b4f2-edb0-4594-a2d2-b16f7b9686b4 | 2026-07-14 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Coupler LLC | 54d77901-f258-bfa1-e063-6294a90aae17 | 2026-06-22 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Coupler LLC | 54d7915f-4aef-79a1-e063-6294a90aa6ef | 2026-06-22 | Warnings, Adverse reactions | YQE403BP4D |
| PHENOBARBITAL | PHENOBARBITAL | Clinical Solutions Wholesale, LLC | 324fde5b-961f-438b-8d9c-b679511dd907 | 2026-06-11 | Warnings, Adverse reactions | YQE403BP4D |
| Phenohytro | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, AND SCOPOLAMINE HYDROBROMIDE | ATLANTIC BIOLOGICALS CORP. | a5aaf1db-1938-4073-9da4-c47f959d013e | 2026-05-19 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Major Pharmaceuticals | e024b80b-c22f-44bc-b273-f9398f840ed0 | 2026-04-30 | Warnings, Adverse reactions | YQE403BP4D |
| PHENOBARBITAL | PHENOBARBITAL | Genus Lifesciences | 074e875d-474a-4bbc-9008-821d63ca9e32 | 2026-04-17 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Westminster Pharmaceuticals, LLC | e0276d32-80b9-4e06-85f9-3421a013be39 | 2026-03-12 | Warnings, Adverse reactions | YQE403BP4D |
| PHENOBARBITAL | PHENOBARBITAL | Clinical Solutions Wholesale, LLC | 40ca1ac5-5228-4430-815f-7be6af6c2833 | 2026-03-04 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Chartwell Governmental & Specialty RX, LLC. | 4616303e-1d91-4888-8156-4ae6bd3891b7 | 2026-02-25 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital Oral Solution | PHENOBARBITAL ORAL | BPI Labs LLC | 45f6317e-cfc9-4ec9-84c9-72daa6c68911 | 2025-12-29 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital Oral Solution | PHENOBARBITAL ORAL | Ajenat Pharmaceuticals LLC | adf9382d-9fa3-4574-bfcd-e92a8b3433e6 | 2025-12-29 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Redpharm Drug | 3252a6bb-02e8-7992-e063-6394a90aec3d | 2025-12-18 | Warnings, Adverse reactions | YQE403BP4D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.